Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Anaptysbio (ANAB) Other Operating Expenses (2023)

Anaptysbio filings provide 1 years of Other Operating Expenses readings, the most recent being $7.3 million for Q4 2023.

  • For the quarter ending Q4 2023, Other Operating Expenses changed N/A year-over-year to $7.3 million, compared with a TTM value of $7.3 million through Sep 2024, changed N/A, and an annual FY2023 reading of $7.3 million, changed N/A over the prior year.
  • Other Operating Expenses hit $7.3 million in Q4 2023 for Anaptysbio.
  • The five-year high for Other Operating Expenses was $7.3 million in Q4 2023, with the low at $7.3 million in Q4 2023.